SCHEMBL17524115

SCHEMBL17524115

CC[C@@H](CCCCN1CCNCC1)CCC(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 2/20 0.41
GNAO1 P09471 5/20 0.37
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
GNAI3 P08754 4/20 0.36
GNAI1 P63096 4/20 0.36
SIGMAR1 Q99720 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.33
POLB P06746 1/20 0.33
SOD3 P08294 2/20 0.32
ALDH1A1 P00352 2/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17524116 1.00 CXCR4 (0.41) CXCR4GNAO1CHRM2CHRM4CHRM5
SCHEMBL17524192 0.98 CXCR4 (0.44) CXCR4GNAO1CHRM2CHRM4CHRM5
SCHEMBL17524190 0.98 CXCR4 (0.44) CXCR4GNAO1CHRM2CHRM4CHRM5
SCHEMBL17524044 0.95 CXCR4 (0.40) CXCR4GNAO1CHRM2CHRM4CHRM5
SCHEMBL17524042 0.95 CXCR4 (0.40) CXCR4GNAO1CHRM2CHRM4CHRM5
SCHEMBL17523883 0.86 CXCR4 (0.40) CXCR4GNAO1CHRM2CHRM4CHRM5
SCHEMBL17523881 0.86 CXCR4 (0.40) CXCR4GNAO1CHRM2CHRM4CHRM5
SCHEMBL17524119 0.86 USP2 (0.33) GNAO1GNAI3GNAI1ALDH1A1KDM4E
SCHEMBL17524117 0.86 CHRM2 (0.37) GNAO1CHRM2CHRM4CHRM5CHRM1
SCHEMBL17524118 0.86 CHRM2 (0.37) GNAO1CHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. (US) 2016-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039879-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF FKBP1B, MALT1, FKBP5 CXCR4 2243/4885GNAO1 4461/4885CHRM2 4339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.